), has announced an early start  of two new acquired immunodeficiency syndrome (AIDS) vaccine clinical (human)  trials. These FDA-compliant trials were earlier scheduled to start later in  2007 and are the third and fourth in a series of four clinical trials intended  to evaluate both human safety and immune responses to GeoVax’s HIV/AIDS  vaccines.

News

GeoVax Labs, Inc. (Atlanta, GA, www.geovax.com), has announced an early start of two new acquired immunodeficiency syndrome (AIDS) vaccine clinical (human) trials.